Leading Nifedipine Companies in Japan | Key Players 2026

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA13183

Publication Date: Jul 2026

Leading Nifedipine Companies in Japan

The following is a data-backed list of the leading Japan Nifedipine companies, compiled through 6Wresearch's proprietary research and validated by in-house industry analysts. These companies represent the key players shaping competition in the Japan Nifedipine Industry, including Bayer, Sawai Pharmaceutical Co., Ltd., and other established names.

For detailed forecasts, data tables, and competitive benchmarking,
Explore the full Japan Nifedipine Industry.

View Main Report Schedule Analyst Call

List of Nifedipine companies in Japan:

1. Bayer

Company Name	Bayer
Established Year	1863
Headquarters	Leverkusen, Germany
Official Website	Click Here

A global pioneer in the calcium channel blocker segment, Bayer provides the original Adalat formulations that set the standard for hypertension and angina treatment.

2. Sawai Pharmaceutical Co., Ltd.

Company Name	Sawai Pharmaceutical Co., Ltd.
Established Year	1929
Headquarters	Osaka, Japan
Official Website	*Click Here*

A major force in the Japanese generic market, Sawai focuses on high-quality, controlled-release nifedipine tablets designed for ease of use by the elderly population.

3. Towa Pharmaceutical Co., Ltd.

Company Name	Towa Pharmaceutical Co., Ltd.
Established Year	1951
Headquarters	Osaka, Japan
Official Website	Click Here

A historic innovator in tech-enabled drug formulation, Towa is renowned for being among the first to offer easy-to-identify generic nifedipine L-tablets for small and medium clinics.

4. Nichi-Iko Pharmaceutical Co., Ltd.

Company Name	Nichi-Iko Pharmaceutical Co., Ltd.
Established Year	1965
Headquarters	Toyama, Japan
Official Website	Click Here

A fast-growing leader in the generic premium segment that provides an end-to-end hypertension management suite, integrating stable drug delivery with patient compliance support.

5. Takeda Pharmaceutical Company Limited

Company Name	Takeda Pharmaceutical Company Limited
Established Year	1781
Headquarters	Tokyo, Japan
Official Website	*Click Here*

Caters to the modern Japanese workforce with an employee-centric platform that emphasizes transparency in pharmaceutical processing and administrative ease for hospital teams.

6. Zensei Pharmaceutical Industries Co., Ltd.

Company Name	Zensei Pharmaceutical Industries Co., Ltd.
Established Year	1951
Headquarters	Osaka, Japan
Official Website	Click Here

Provides high-durability nifedipine CR tablet processing and drug management solutions, supporting some of the largest regional medical frameworks in the country.

7. Meiji Seika Pharma Co., Ltd.

Company Name	Meiji Seika Pharma Co., Ltd.
Established Year	1916
Headquarters	Tokyo, Japan
Official Website	Click Here

An integrated biopharma firm that leverages robust supply chains to support essential cardiovascular medicine availability across Japan’s diverse pharmacy networks.

8. Yoshindo Inc.

Company Name	Yoshindo Inc.
Established Year	1929
Headquarters	Toyama, Japan
Official Website	-

Focuses on long-term pharmaceutical stability and advanced drug delivery, ensuring consistent access to essential blood pressure medications for hospital-based patients.